Related Experiment Video
Updated: Oct 7, 2026

A Simple Protocol for Platelet-mediated Clumping of Plasmodium falciparum-infected Erythrocytes in a Resource Poor Setting
Published on: May 16, 2013
Intraleucocytic malaria pigment and clinical severity of malaria in children
O K Amodu1, A A Adeyemo, P E Olumese
1Department of Clinical Pharmacology, University College Hospital, Ibadan, Nigeria. sysop@nga.healthnet.org
Insights
The proportion of neutrophils containing malaria pigment increases with disease severity in children. This simple count can help assess the severity of childhood malaria.
Area of Science:
- Tropical Medicine
- Infectious Diseases
- Pediatrics
Background:
- Intraleucocytic malaria pigment has been proposed as a potential indicator of malaria severity.
- Childhood malaria remains a significant public health challenge, particularly in high-transmission areas of Africa.
- Accurate and simple markers for assessing malaria severity are crucial for effective patient management.
Purpose of the Study:
- To evaluate the hypothesis that intraleucocytic malaria pigment, specifically in neutrophils and monocytes, correlates with malaria disease severity in children.
- To determine if the proportion of pigment-containing neutrophils and monocytes can serve as a simple marker for childhood malaria severity.
Main Methods:
- A study was conducted on 146 children (6 months to 14 years) in Ibadan, Nigeria, categorized into cerebral malaria, mild malaria, asymptomatic malaria, and no malaria groups.
- Blood samples were analyzed to determine the proportion of neutrophils and monocytes containing malaria pigment.
- Statistical analysis was performed to compare pigment levels across the different disease severity groups.
Main Results:
- A significant and clear increase in the proportion of pigment-containing neutrophils was observed across the spectrum from no malaria to cerebral malaria (median values: 2.0% to 27.0%, P < 0.0001).
- While pigment-containing monocytes showed no significant difference between mild, asymptomatic, and no malaria groups, the cerebral malaria group had a higher median value.
- The ratio of pigment-containing neutrophils to monocytes mirrored the trend observed with neutrophils alone, reinforcing the association with disease severity.
Conclusions:
- The count of pigment-containing neutrophils is a simple and effective marker for assessing disease severity in childhood malaria.
- This finding adds a valuable, easily measurable parameter to complement parasite counts in the clinical management of pediatric malaria.
- The study supports the utility of intraleucocytic malaria pigment as a readily available indicator of malaria severity in endemic regions.
Abstract:
Intraleucocytic malaria pigment has been suggested as a measure of disease severity in malaria. We have tested this hypothesis by studying 146 children aged 6 months to 14 years in 4 categories--cerebral malaria, mild malaria, asymptomatic malaria and 'no malaria'--in Ibadan, Nigeria, an area of intense malaria transmission in Africa. Children with cerebral malaria were studied at the university hospital, those with mild malaria at 2 primary health centres and the other 2 groups were studied in a primary school. The proportion of pigment-containing neutrophils showed a clear rise across the spectrum no malaria--asymptomatic malaria--mild malaria--cerebral malaria (median values 2.0%, 6.5%, 9.0% and 27.0%, respectively; P < 0.0001). The proportion of pigment-containing monocytes did not differ significantly between the mild malaria, asymptomatic malaria and no malaria groups but the cerebral malaria group had a higher median value than the other 3 groups. The ratio of pigment-containing neutrophils to pigment-containing monocytes showed the same trend across the groups of subjects as was observed with the number of pigment-containing neutrophils. It is concluded that the pigment-containing neutrophil count is a simple marker of disease severity in childhood malaria in addition to the parasite count.
Related Concept Videos
Symbiosis
Leishmaniasis
Malaria
Antiprotozoal Agents

